31
TÍTULO: A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes  Full Text
AUTORES: Kristel Van Laethem; Yoeri Schrooten; Kris Covens; Nathalie Dekeersmaeker; Paul De Munter; Eric Van Wijngaerden; Marc Van Ranst; Anne Mieke Vandamme;
PUBLICAÇÃO: 2008, FONTE: JOURNAL OF VIROLOGICAL METHODS, VOLUME: 153, NÚMERO: 2
INDEXADO EM: Scopus WOS CrossRef
32
TÍTULO: Impact on Replicative Fitness of the G48E Substitution in the Protease of HIV-1. An In Vitro and In Silico Evaluation
AUTORES: Jean-Marie Zimmer; François Roman; Christine Lambert; Abel Jonckheer; Ana Vazquez; Jean-Marc Plesséria; Jean-Yves Servais; Kris Covens; Jan Weber; Kristel Van Laethem; Jean-Claude Schmit; Anne-Mieke Vandamme; Miguel E Quinones-Mateu; Marc De Maeyer;
PUBLICAÇÃO: 2008, FONTE: JAIDS Journal of Acquired Immune Deficiency Syndromes, VOLUME: 48, NÚMERO: 3
INDEXADO EM: CrossRef
33
TÍTULO: Estimating the relative contribution of dNTP pool imbalance and APOBEC3G/3F editing to HIV evolution in vivo
AUTORES: Koen Deforche; Ricardo Camacho; Kristel Van Laethem; Beth Shapiro; Yves Moreau; Andrew Rambaut; Anne Mieke Vandamme ; Philippe Lemey;
PUBLICAÇÃO: 2007, FONTE: JOURNAL OF COMPUTATIONAL BIOLOGY, VOLUME: 14, NÚMERO: 8
INDEXADO EM: Scopus WOS CrossRef
34
TÍTULO: Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors  Full Text
AUTORES: Deforche, K; Camacho, R; Grossman, Z; Silander, T; Soares, MA; Moreau, Y; Shafer, RW; Van Laethem, K; Carvalho, AP; Wynhoven, B; Cane, P; Snoeck, J; Clarke, J; Sirivichayakul, S; Ariyoshi, K; Holguin, A; Rudich, H; Rodrigues, R; Bouzas, MB; Cahn, P; Brigido, LF; Soriano, V; Sugiura, W; Phanuphak, P; Morris, L; Weber, J; Pillay, D; Tanuri, A; Harrigan, PR; Shapiro, JM; Katzenstein, DA; Kantor, R; Vandamme, AM ; ...Mais
PUBLICAÇÃO: 2007, FONTE: 11th International Workshop on Virus Evolution and Molecular Epidemiology in INFECTION GENETICS AND EVOLUTION, VOLUME: 7, NÚMERO: 3
INDEXADO EM: Scopus WOS CrossRef
35
TÍTULO: Proof-of-principle evaluation of predictive performance for therapy outcome of baseline estimated fitness and genetic barrier towards resistance in a clinical cohort of HIV-1-treated patients
AUTORES: Deforche, K; Cozzi Lepri, A; Theys, K; Clotet, B; Camacho, R; Kjaer, J; Van Laethem, K; Phillips, AN; Moreau, Y; Lundgren, JD; Vandamme, AM;
PUBLICAÇÃO: 2007, FONTE: 16th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 12
INDEXADO EM: WOS
36
TÍTULO: Proof-of-principle evaluation of predictive performance for therapy outcome of baseline estimated fitness and genetic barrier towards resistance in a clinical cohort of HIV-1-treated patients
AUTORES: Deforche, K; Cozzi Lepri, A; Theys, K; Clotet, B; Camacho, R; Kjaer, J; Van Laethem, K; Phillips, AN; Moreau, Y; Lundgren, JD; Vandamme, AM;
PUBLICAÇÃO: 2007, FONTE: 16th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 12, NÚMERO: 5
INDEXADO EM: WOS
39
TÍTULO: Current genotypic interpretation systems are comparable in their predictive ability and highly dependent on identifying the most active protease inhibitor
AUTORES: Rhe, SY; Fessel, WJ; Marlowe, NM; Rowland, CM; Vandamme, AM; Van Laethem, K; Brun Vezinet, F; Calvez, V; Shafer, RW;
PUBLICAÇÃO: 2007, FONTE: 16th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 12, NÚMERO: 5
INDEXADO EM: WOS
40
TÍTULO: Foscarnet selects for a D113V mutation within the Q151M cluster that suppresses zidovudine resistance
AUTORES: Van Laethem, K; Pannecouque, C; Scarth, B; Gotte, M; Vandamme, AM;
PUBLICAÇÃO: 2007, FONTE: 16th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 12, NÚMERO: 5
INDEXADO EM: WOS
Página 4 de 8. Total de resultados: 80.